Pitolisant
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 231 publications
Therapeutic potential of histamine N-methyltransferase inhibition for the treatment of hypersomnia
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: March 01, 2026
Samelisant (SUVN-G3031), a histamine H3 receptor inverse agonist, as a potential treatment for narcolepsy: a phase-2 Drug evaluation.
Journal: Expert opinion on investigational drugs
Published: February 23, 2026
Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds-Histamine H3 Receptor Ligands and MAO-B Inhibitors.
Journal: International journal of molecular sciences
Published: December 05, 2025
Efficacy and Safety of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy and Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Journal: The Annals of pharmacotherapy
Published: December 01, 2025
Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.
Journal: Drugs
Published: November 26, 2025
Reciprocal regulation of the H3 histamine receptor in Rett syndrome and MECP2 Duplication syndrome: implications for therapeutic development.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
A real-world study on the treatment of pediatric narcolepsy with pitolisant in China.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: November 03, 2025
Pharmacological modulation of wakefulness and extracellular hypothalamic histamine release in adult male mice using TAK-925, modafinil, pitolisant, MK-8133 and Lu AF11167.
Journal: Neuropharmacology
Published: October 15, 2025
Drug Interactions With Excessive Daytime Sleepiness Treatments.
Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
Published: October 07, 2025
Understanding idiopathic hypersomnia: diagnosis, pathophysiology, and management.
Journal: Current opinion in pulmonary medicine
Published: September 24, 2025
Pitolisant may lessen not only sleepiness but improve hyperphagia and behavior problems in Prader-Willi syndrome.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: September 12, 2025
Last Updated: 04/28/2026